| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |